Omeprazol Sandoz (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Sandoz, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Sandoz is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens: used as part of triple‑therapy to improve eradication rates. - NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term NSAID therapy.

Omeprazol Sandoz is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation: occasional. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema). - Clostridioides difficile‑associated colitis. - Low magnesium levels (hypomagnesemia) with prolonged use. - Bone fracture risk with long‑term high‑dose therapy. - Acute interstitial nephritis. - Liver enzyme abnormalities.

Before starting Omeprazol Sandoz, consider the following precautions: - Assess renal and hepatic function: dose adjustment may be needed in severe impairment. - Review long‑term use: prolonged therapy may increase risk of fractures, infections, and nutrient deficiencies. - Monitor for drug interactions: especially with antiplatelet agents, warfarin, and HIV protease inhibitors. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Pediatric use: safety and efficacy established for specific age groups; follow prescribing information. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazol Sandoz can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, consider alternative therapy. - Atazanavir or other protease inhibitors: markedly decreased antiviral exposure. - Methotrexate (high dose): increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation parameters. - Digoxin: may increase serum levels, observe for toxicity signs. - Phenytoin: reduced clearance, monitor seizure control. - Iron supplements: decreased absorption, separate dosing by at least 2 hours.